These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12731414)

  • 1. [Colorectal cancer in Germany. Means for prevention and early detection: implications for laiety and physicians].
    Eickhoff A; Maar C; Birkner B; Riemann JF
    Internist (Berl); 2003 Mar; 44(3):278, 281-6. PubMed ID: 12731414
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonoscopy as a mass screening tool.
    Lieberman D
    Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):225-8. PubMed ID: 9585025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the most cost-effective screening regimen for colon cancer?
    Griffith S; Kane KY
    J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for colon cancer: economics and related considerations.
    Gelfand DW
    Semin Roentgenol; 1996 Apr; 31(2):170-6. PubMed ID: 8848734
    [No Abstract]   [Full Text] [Related]  

  • 6. Summaries for patients. Screening for colorectal cancer: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jul; 137(2):I38. PubMed ID: 12118986
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 8. Fecal occult blood testing: best option for colorectal cancer screening in Asia?
    Sharma SP
    J Natl Cancer Inst; 2008 Aug; 100(15):1056-7. PubMed ID: 18664644
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of cost-effective strategies in colorectal cancer screening].
    Dervaux B; Eeckhoudt L; Lebrun T; Sailly JC
    Rev Epidemiol Sante Publique; 1992; 40(5):296-306. PubMed ID: 1480806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for colorectal cancer: a cost benefit analysis on a health prevention programme at the Boehringer Ingelheim Company].
    Schneider M; Häck HJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1047-52. PubMed ID: 21560104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of colorectal cancer: pay now or pay later.
    Lewis JD
    Ann Intern Med; 2000 Oct; 133(8):647-9. PubMed ID: 11033594
    [No Abstract]   [Full Text] [Related]  

  • 12. Colorectal cancer screening in Italy: feasibility and cost-effectiveness in a model area.
    Sorrentino D; Paduano R; Bernardis V; Piccolo A; Bartoli E
    Eur J Gastroenterol Hepatol; 1999 Jun; 11(6):655-60. PubMed ID: 10418938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass screening for colorectal cancer: are we ready?
    Clayman CB
    JAMA; 1989 Jan; 261(4):609. PubMed ID: 2491895
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for colorectal cancer: the light at the end of the tunnel.
    Caprilli R; Taddei G
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):109-13. PubMed ID: 9646188
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
    [No Abstract]   [Full Text] [Related]  

  • 17. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for colorectal cancer: what is the most cost-effective approach?
    Bolin TD; Lapsley HM; Korman MG
    Med J Aust; 2001 Mar; 174(6):298-301. PubMed ID: 11297120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z; Davari M; Emami MH
    Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.